• Je něco špatně v tomto záznamu ?

The role of autophagic cell death and apoptosis in irinotecan-treated p53 null colon cancer cells

J. Stanislav, J. Mls, M. Červinka, E. Rudolf,

. 2013 ; 13 (5) : 811-20.

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc14051247

The roles of autophagic cell death and apoptosis induced by topoisomerase inhibitor irinotecan in colon cancer cells with deleted p53 were investigated during 48 h. We report that irinotecan-dependent cytotoxicity and proapoptotic activity were reduced in the present model while autophagy levels significantly increased. Upon p53 transfection, cell demise rates increased, with cells bearing the features of apoptosis and autophagic cell death. The subsequent studies into mechanisms of cell death process revealed the important role of Bax in mediating mitochondrial and lysosomal leakage which might serve as leading signals for both apoptosis and autophagic cell death. These results suggest that different modes of cell death in p53 null colon cancer cells treated with cytostatics (irinotecan) may be activated simultaneously. Moreover, their interactions possibly occur at several stages and aren't mutually exclusive. This might thus lead to a potential synergism with interesting therapeutic ramifications.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14051247
003      
CZ-PrNML
005      
20140408110904.0
007      
ta
008      
140401s2013 ne f 000 0|eng||
009      
AR
024    7_
$a 10.2174/1871520611313050015 $2 doi
035    __
$a (PubMed)22721392
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Stanislav, John
245    14
$a The role of autophagic cell death and apoptosis in irinotecan-treated p53 null colon cancer cells / $c J. Stanislav, J. Mls, M. Červinka, E. Rudolf,
520    9_
$a The roles of autophagic cell death and apoptosis induced by topoisomerase inhibitor irinotecan in colon cancer cells with deleted p53 were investigated during 48 h. We report that irinotecan-dependent cytotoxicity and proapoptotic activity were reduced in the present model while autophagy levels significantly increased. Upon p53 transfection, cell demise rates increased, with cells bearing the features of apoptosis and autophagic cell death. The subsequent studies into mechanisms of cell death process revealed the important role of Bax in mediating mitochondrial and lysosomal leakage which might serve as leading signals for both apoptosis and autophagic cell death. These results suggest that different modes of cell death in p53 null colon cancer cells treated with cytostatics (irinotecan) may be activated simultaneously. Moreover, their interactions possibly occur at several stages and aren't mutually exclusive. This might thus lead to a potential synergism with interesting therapeutic ramifications.
650    _2
$a antitumorózní látky fytogenní $x farmakologie $x terapeutické užití $7 D000972
650    _2
$a apoptóza $x účinky léků $x fyziologie $7 D017209
650    _2
$a autofagie $x účinky léků $x fyziologie $7 D001343
650    _2
$a kamptothecin $x analogy a deriváty $x farmakologie $x terapeutické užití $7 D002166
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a nádory tračníku $x farmakoterapie $x genetika $x metabolismus $7 D003110
650    _2
$a HCT116 buňky $7 D045325
650    _2
$a buňky HT-29 $7 D019073
650    _2
$a lidé $7 D006801
650    _2
$a nádorový supresorový protein p53 $x nedostatek $x genetika $7 D016159
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Mls, Jan $u -
700    1_
$a Červinka, Miroslav $u -
700    1_
$a Rudolf, Emil $u -
773    0_
$w MED00172590 $t Anti-cancer agents in medicinal chemistry $x 1875-5992 $g Roč. 13, č. 5 (2013), s. 811-20
856    41
$u https://pubmed.ncbi.nlm.nih.gov/22721392 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20140401 $b ABA008
991    __
$a 20140408110952 $b ABA008
999    __
$a ok $b bmc $g 1018383 $s 849827
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2013 $b 13 $c 5 $d 811-20 $i 1875-5992 $m Anti-cancer agents in medicinal chemistry $n Anticancer Agents Med Chem $x MED00172590
LZP    __
$a Pubmed-20140401

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...